You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
|
|---|---|
| Published in |
Clinical Cancer Research, January 2020
|
| DOI | 10.1158/1078-0432.ccr-19-1104 |
| Pubmed ID | |
| Authors |
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z. Rizvi, Rosa L. Frias, Jean Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Braye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary, Eric Angevin, Alexander M. Eggermont, Fabrice Andre, Christophe Massard, Ken A. Olaussen, Jean-Charles Soria, Benjamin Besse, Luc Friboulet |
X Demographics
The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 12% |
| France | 6 | 10% |
| Switzerland | 4 | 7% |
| Italy | 4 | 7% |
| United Kingdom | 3 | 5% |
| Spain | 2 | 3% |
| Argentina | 1 | 2% |
| Brazil | 1 | 2% |
| Australia | 1 | 2% |
| Other | 6 | 10% |
| Unknown | 23 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 53% |
| Scientists | 14 | 24% |
| Practitioners (doctors, other healthcare professionals) | 10 | 17% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 110 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 16% |
| Student > Ph. D. Student | 16 | 15% |
| Other | 14 | 13% |
| Student > Bachelor | 6 | 5% |
| Student > Master | 5 | 5% |
| Other | 11 | 10% |
| Unknown | 40 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 23% |
| Biochemistry, Genetics and Molecular Biology | 15 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Agricultural and Biological Sciences | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Other | 9 | 8% |
| Unknown | 52 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#895,641
of 25,837,817 outputs
Outputs from Clinical Cancer Research
#582
of 13,309 outputs
Outputs of similar age
#21,792
of 480,321 outputs
Outputs of similar age from Clinical Cancer Research
#23
of 185 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,309 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,321 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.